Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 5129-5136, November 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rishi, A. K.
Right arrow Articles by Fontana, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rishi, A. K.
Right arrow Articles by Fontana, J. A.

Transcriptional Repression of the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 Gene Mediated by cis Elements Present in the 3'-Untranslated Region1

Arun K. Rishi2, C. K. Alex Hsu, Xiao-Su Li, Arif Hussain, Tonya M. Gerald and Joseph A. Fontana

Department of Medicine, Division of Oncology and Greenebaum Cancer Center [A. K. R., C. K. A. H., X-S. L., A. H., J. A. F.], and Department of Biochemistry [T. M. G.], University of Maryland School of Medicine, and Veterans Affairs Medical Center [J. A. F.], Baltimore, Maryland 21201

The cyclin-dependent kinase inhibitor p21WAF1/CIP1 plays a major role in the induction of G1 cell cycle arrest following DNA damage and is known to be regulated by p53-dependent and -independent pathways. Here, we show that p21WAF1/CIP1 transcription is also regulated, independently of p53, by the cis elements that are located downstream of the transcription start site. A cDNA fragment of ~180 bp, located 260 bases 3' to the translation termination codon of p21WAF1/CIP1 cDNA, was cloned in both the sense and antisense orientations downstream of the CMV promoter, upstream of the SV40 promoter, and both upstream and downstream of the p21WAF1/CIP1 promoter in the plasmids carrying the luciferase reporter gene. The constructs were transiently transfected in human breast carcinoma cells MCF-7 and MDA-MB-468 and a Syrian hamster smooth muscle cell line DDT1MF2 and were found to elicit 2–3-fold or higher repression of luciferase activities. By using overlapping deletions of the above 180-bp fragment, we identified a 48-bp subfragment that contains putative cis element(s) that participate in the transcriptional repression of the p21WAF1/CIP1 gene. The overlapping subfragments bind, in vitro, to specific proteins present in the nuclear extracts of MDA-MB-468 and DDT1MF2 cells. We, therefore, propose that additional mechanism(s) exist that regulate expression of the cellular p21WAF1/CIP1 and may contribute to p21WAF1/CIP1-dependent control of the cell cycle.

1 This work was supported in part by the Medical Research Services of the Department of Veterans Affairs, by NIH Grant CA-63335 (to J. A. F.), by a University of Maryland Institutional Research Award (to A. K. R.), and V. A. Cancer Development Award (to A. H.).

2 To whom requests for reprints should be addressed, at Greenebaum Cancer Center, University of Maryland, Bressler Research Building, Room 9-031, 655 West Baltimore Street, Baltimore, MD 21201.

Received 6/ 5/97. Accepted 9/19/97.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene
PNAS, April 1, 2008; 105(13): 5160 - 5165.



Home page
Cancer Res.Home page
L. Zhang, A. Wali, C. V. Ramana, and A. K. Rishi
Cell Growth Inhibition by Okadaic Acid Involves Gut-Enriched Kruppel-like Factor Mediated Enhanced Expression of c-Myc
Cancer Res., November 1, 2007; 67(21): 10198 - 10206.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
S. Yamashita, K. Wakazono, T. Nomoto, Y. Tsujino, T. Kuramoto, and T. Ushijima
Expression Quantitative Trait Loci Analysis of 13 Genes in the Rat Prostate
Genetics, November 1, 2005; 171(3): 1231 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Manjeshwar, D. E. Branam, M. R. Lerner, D. J. Brackett, and E. R. Jupe
Tumor Suppression by the Prohibitin Gene 3'Untranslated Region RNA in Human Breast Cancer
Cancer Res., September 1, 2003; 63(17): 5251 - 5256.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhang, A. K. Rishi, M. I. Dawson, R. Tschang, L. Farhana, M. Boyanapalli, U. Reichert, B. Shroot, E. C. Van Buren, and J. A. Fontana
S-phase Arrest and Apoptosis Induced in Normal Mammary Epithelial Cells by a Novel Retinoid
Cancer Res., April 1, 2000; 60(7): 2025 - 2032.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
M. E. Bottazzi, X. Zhu, R. M. Bohmer, and R. K. Assoian
Regulation of p21cip1 Expression by Growth Factors and the Extracellular Matrix Reveals a Role for Transient ERK Activity in G1 Phase
J. Cell Biol., September 20, 1999; 146(6): 1255 - 1264.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.